Total Skin and Beauty Dermatology Center | Birmingham, AL

Research site
2100 16th Avenue South Suite 202, Birmingham, Alabama, United States of America

Site insights

Top conditions

Top treatments


Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 6 total trials

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

The main aim of this study is to show how well TAK-279 reduces the skin plaques compared to placebo, in participants with moderate-to-severe plaque p...

Plaque Psoriasis
Drug: Placebo
Drug: TAK-279

The masseter muscle is one of the muscles in the lower face used for chewing. The prominence of the masseter muscle can appear as a widened lower fac...

Masseter Muscle Prominence
Drug: Placebo

Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and fa...

Alopecia Areata
Drug: Placebo
Drug: Upadacitinib
Locations recently updated

Psoriasis is a long-term skin disease which causes red, itchy, scaly patches most commonly on the knees, elbows, scalp, and torso (chest, back, and a...

Moderate Plaque Psoriasis
Drug: Risankizumab
Drug: Deucravacitinib

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in a...

Alopecia Areata
Drug: CTP-543

Trial sponsors

AbbVie logo
Concert Pharmaceuticals logo
Takeda logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems